TrumpRx

What TrumpRx does

TrumpRx is a U.S. federal government-operated direct-to-consumer prescription drug pricing platform launched in February 2026 by the Trump administration as the consumer-facing layer of its Most Favored Nation (MFN) drug pricing initiative. The platform connects cash-paying, uninsured, and high-deductible Americans with discounted prescription medicines at 33-95% off list prices, aggregating offers from pharmaceutical manufacturers that have agreed to MFN pricing in exchange for tariff exemptions. It serves only self-pay patients — it does not accept insurance, cannot be combined with government programs (Medicare, Medicaid, TRICARE, VA, DOD), and does not count toward deductibles. The platform does not sell drugs directly, does not generate revenue, and functions as a price-comparison and coupon-distribution mechanism rather than a commercial marketplace.

The platform's technology stack is a government web portal (trumprx.gov) hosted on Cloudflare, with AWS Location Services for geolocation-based pharmacy lookup, and GoodRx's pricing engine as the core integration powering discounted cash-price display for 30+ Pfizer brand medications at launch. The product surface splits into two offerings: "Presidential Deals" — 79 brand-name medications with MFN-negotiated pricing from 17 manufacturers (Pfizer, Eli Lilly, Novo Nordisk, AstraZeneca, AbbVie, Novartis, Bristol Myers Squibb, Sanofi, Boehringer Ingelheim, Amgen, Genentech, Merck, EMD Serono, and others) — and a generic catalog of 600+ medicines sourced from Amazon Pharmacy, Cost Plus Drugs, and GoodRx. Fulfillment is routed through manufacturer direct-order sites (LillyDirect, AstraZeneca Direct, Novartis Direct-to-Patient, BMS Patient Connect, Boehringer Ingelheim Direct, Sanofi Patient Connection), approximately 9,000 CVS Health community pharmacies for coupon redemption, and home delivery via Amazon Pharmacy.

The business model is non-commercial and policy-driven. Pharmaceutical manufacturers provide discounted cash prices in exchange for tariff-exemption relief negotiated by the administration; TrumpRx aggregates and publishes those offers without taking a margin, charging no fees, and collecting no commissions. Customer segments include uninsured Americans (~15% of the U.S. population, per the input data), self-paying cash patients, high-deductible plan holders, and demand-driven seekers of GLP-1 weight-loss medications and IVF fertility treatments. The platform is overseen by HHS Secretary Robert F. Kennedy Jr. and CMS Administrator Dr. Mehmet Oz, and the displayed consumer-savings counter exceeded $400M by May 24, 2026.

Name

TrumpRx

Legal name

TrumpRx (U.S. Federal Government Program)

Website

https://trumprx.gov

Company type

Private

Founded year

2026

Operating status

Operating

Short description

TrumpRx is a U.S. federal government platform launched in February 2026 that connects cash-paying patients with discounted prescription drugs via Most Favored Nation pricing agreements with 17 pharmaceutical manufacturers and pharmacy partners including CVS, Amazon Pharmacy, and Cost Plus Drugs.

Ownership category

akta.pro rank

Product category

Government Prescription Drug Pricing Platform

NAICS

Pharmacies and Drug Retailers (456110)

SIC

Retail-Drug Stores And Proprietary Stores (5912)

akta.pro primary industry

Government Pricing & Compliance (Medicare/Medicaid/340B/AMP/Best Price) (HLAIAKAE)

akta.pro secondary industries

Pharmacy & Health Essentials Delivery (CRAFAFAI), Discount Drugstores (Value-Focused Chain Pharmacies) (CRAEAHAA), PBM Technology Platforms (ePA/eRx/Real-Time Benefit Tools) (HLAEAKAL)

Keywords

• Prescription drug pricing
• Government health platform
• Patient drug discounts
• Most favored nation pricing
• Cash pay pharmacy

GTM type

B2C

Offering type

Services

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Not Applicable - Government Initiative: TrumpRx is a U.S. government portal that does not sell drugs directly, accept insurance, or generate revenue. It serves as a price comparison and coupon distribution platform enabling patients to obtain discounted medications from pharmaceutical manufacturers. The initiative was part of tariff exemption negotiations with pharmaceutical companies.

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels5 records

Core offering

TrumpRx is a U.S. federal government-operated direct-to-consumer portal (trumprx.gov) that connects patients with discounted prescription medicines from pharmaceutical manufacturers at Most-Favored-Nation prices negotiated in exchange for tariff exemptions. The platform distributes digital pharmacy coupons and redirects patients to manufacturer direct-order sites or partner pharmacies (CVS, Amazon Pharmacy, Cost Plus Drugs), bypassing traditional Pharmacy Benefit Managers. It offers 79 brand-name medications at 33–95% off list prices plus 600+ generic drugs, free to use for self-pay patients without insurance.

Product overview

TrumpRx is a federal government-operated direct-to-consumer prescription drug pricing platform launched by the Trump administration in February 2026. The platform enables cash-paying patients to access discounted medications through two main offerings: Presidential Deals featuring brand-name drugs with prices negotiated through Most-Favored-Nation agreements with pharmaceutical manufacturers, and Generic Drugs sourced from retail and mail-order pharmacy partners. The platform currently lists 79 brand-name medications with discounts up to 95% off original prices, plus hundreds of generic alternatives. Key featured drugs include GLP-1 weight-loss medications (Wegovy, Ozempic, Zepbound), diabetes treatments (Farxiga, Xigduo XR, Jentadueto), fertility treatments (Gonal-F, Cetrotide, Ovidrel), and specialty medications for conditions like multiple sclerosis and autoimmune diseases. The platform aggregates pricing from pharmaceutical manufacturers and integrates with GoodRx for pricing data, CVS Health for retail pharmacy acceptance, Amazon Pharmacy and Cost Plus Drugs for generic mail-order delivery.

Differentiator

Problem solved

Functional benefit

Products and services

• TrumpRx Presidential Deals (Brand-Name Drugs) Brand-name prescription medications with prices negotiated by the Trump administration through Most-Favored-Nation pricing agreements with 17 pharmaceutical manufacturers, offering savings of up to 95% off original list prices. Targets uninsured/self-pay U.S. consumers; coupons redeemed at retail pharmacies or via manufacturer direct-order sites.
• TrumpRx Generic Drugs Generic prescription medications offered at discounted standard prices through retail and mail-order pharmacy partners including Amazon Pharmacy and Cost Plus Drugs, providing lower-cost alternatives to brand-name drugs for self-pay patients.
• Wegovy Pill (Semaglutide) Novo Nordisk's GLP-1 weight-loss medication in oral tablet form, available at $149/month (limited-time offer) compared to original price of $1,349.02, representing 78-89% savings for cash-pay patients through TrumpRx.
• Wegovy Pen (Semaglutide) Novo Nordisk's GLP-1 injectable weight-loss medication, available at $199/month for new patients' first two monthly fills (0.25mg/0.5mg) and $349/month standard, versus original price of $1,349. Represents 70-85% savings for cash-pay patients via TrumpRx.
• Ozempic Pen (Semaglutide) Novo Nordisk's GLP-1 diabetes treatment and weight-loss injectable, available at $199/month for new patients' first two fills and $349/month standard (vs. $1,027.51 original; $499/month for 2mg). Represents 51-81% savings through TrumpRx for self-pay patients.
• Zepbound Vial (Tirzepatide) Eli Lilly's GLP-1 weight-loss medication available through LillyDirect, offering up to 72% savings with original price of $1,087.00 reduced to $299/month (Tirzepatide active ingredient).
• Combigan (Brimonidine/Timolol) AbbVie ophthalmic solution for glaucoma available at $10.00 compared to original price of $204.13, representing 95% savings—the deepest discount on the TrumpRx platform.
• Mayzent (Siponimod) Novartis medication for multiple sclerosis available starting at $42.00 compared to original price of $623.00, representing 90-93% savings through Novartis Direct-to-Patient program for self-paying patients.
• Cetrotide (Cetrorelix) EMD Serono fertility medication available at $22.50 compared to original price of $316.12, representing 93% savings. Part of TrumpRx fertility treatment program.
• Xigduo XR (Dapagliflozin/Metformin) AstraZeneca type-2 diabetes combination medication available at $45.00 compared to original price of $599.72, representing 92% savings through TrumpRx.
• Toujeo (Insulin Glargine) Sanofi long-acting insulin available starting at $35.00 compared to original price of $428.57, representing 92% savings through Sanofi Patient Connection program.
• Farxiga (Dapagliflozin) AstraZeneca diabetes and heart failure medication (SGLT2 inhibitor) available at $35.00 compared to original price of $377.82, representing 91% savings through TrumpRx.
• Humira Pen (Adalimumab) AbbVie autoimmune-disease biologic (TNF inhibitor) for rheumatoid arthritis, psoriasis, Crohn's and other conditions, available at $950.00 compared to original price of $6,922.62, representing 86% savings through TrumpRx.
• Zeposia (Ozanimod) Bristol Myers Squibb sphingosine-1-phosphate receptor modulator for multiple sclerosis and ulcerative colitis available starting at $925.00 compared to original price of $9,707.95, representing 88-90% savings.
• Gonal-F (Follitropin Alfa) EMD Serono fertility medication (follicle-stimulating hormone) available starting at $168.00 compared to original price of $966.04, representing 83% savings. Part of the TrumpRx fertility treatment program.
• Jentadueto / Jentadueto XR (Linagliptin/Metformin) Boehringer Ingelheim type-2 diabetes combination medication (DPP-4 inhibitor + metformin) available starting at $55.00 versus original price of $525.08, representing up to 90% savings through TrumpRx.
• Ozempic Pill (Oral Semaglutide) Novo Nordisk's oral GLP-1 diabetes/weight-loss tablet formulation available through TrumpRx at $149/month (limited-time offer) compared to original price of $1,027.51, representing 71-85% savings.
• Dapagliflozin Propanediol (Generic Farxiga) Generic equivalent of Farxiga (dapagliflozin) available through Amazon Pharmacy with Prime ($8.00 for 30 tablets, 5mg) or Cost Plus Drugs ($13.26), offering lower-cost alternatives to the brand-name version ($35.00, 77% off).

Quantifiable outcome

• $400 million+ saved for Americans
• +3 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

Feature3 records

Partnerships

14 partnerships are on record, tiered secondary and core.

• AbbViesecondaryStrategic or Co-development Partner · 24 May 2026Pharmaceutical partner offering Combigan (95% off) and Humira Pen (86% off) through TrumpRx. Self-pay only program operating outside of third-party health benefit plans.
• NovartissecondaryStrategic or Co-development Partner · 24 May 2026Offers Mayzent (90-93% off) through Novartis Direct-to-Patient program for self-paying patients.
• Bristol Myers SquibbsecondaryStrategic or Co-development Partner · 24 May 2026Offers Zeposia (88-90% off) and Sotyktu (90% off) through BMS Patient Connect direct-order program.
• SanofisecondaryStrategic or Co-development Partner · 24 May 2026Offers Toujeo insulin (92% off) through Sanofi Patient Connection program for self-paying patients.
• Amazon PharmacysecondaryChannel Partner/ Reseller/ Distributor · 19 May 2026Integrated as a home delivery pharmacy option for generic medications, offering 1-4 day delivery and same-day delivery for eligible prescriptions.
• Cost Plus Drugs (Mark Cuban's Company)coreChannel Partner/ Reseller/ Distributor · 18 April 2026Mark Cuban's Cost Plus Drug Company supplies 559 of the drugs on the TrumpRx platform, described as a 'special partnership' by Cuban. Cost Plus Drugs uses a model of manufacturing cost plus 15% markup, $5 pharmacy labor fee, and roughly $5 shipping.
• Boehringer IngelheimsecondaryStrategic or Co-development Partner · 24 March 2026German drugmaker added three drugs (Jentadueto, Jentadueto XR, and Striverdi Respimat) to TrumpRx, offering discounts up to 90% off retail prices. Part of December agreement with Trump administration.
• GoodRxcoreTechnology or Integration · 6 February 2026GoodRx serves as a key integration partner for TrumpRx, powering discounted cash prices for over 30 of Pfizer's essential brand medications at launch. The partnership covers medications spanning women's health, migraine, arthritis, and rare diseases with savings reaching up to 85% and averaging 50% for primary care treatments.
• AstraZenecacoreStrategic or Co-development Partner · 6 February 2026One of five major pharmaceutical companies participating in Most Favored Nation pricing deals at launch. Offers medications including Farxiga, Xigduo XR, and Bevespi through AstraZeneca Direct.
• Eli LillycoreStrategic or Co-development Partner · 6 February 2026Major pharmaceutical partner offering Zepbound and other medications through LillyDirect. Agreed to offer GLP-1 weight-loss drugs at discounted rates of $149-$350 per month through TrumpRx.
• Novo NordiskcoreStrategic or Co-development Partner · 6 February 2026Major pharmaceutical partner offering Ozempic and Wegovy through TrumpRx. Reduced prices from $1,349 to $199 per month for Wegovy in exchange for tariff exemptions.
• PfizercoreStrategic or Co-development Partner · 6 February 2026First major pharmaceutical company to sign agreements with the Trump administration. First deal announced in exchange for three-year tariff grace period. Offers over 30 essential brand medications through GoodRx integration.
• EMD SeronocoreStrategic or Co-development Partner · 6 February 2026Pharmaceutical partner offering fertility medications including Gonal-F, Cetrotide, and Ovidrel through TrumpRx with discounts up to 93%.
• CVS HealthcoreChannel Partner/ Reseller/ Distributor · 6 February 2026Approximately 9,000 CVS community pharmacies accepting TrumpRx discount cards for eligible patients. Additionally serves as retail partner for NovoCare and supports patients accessing reduced pricing on fertility medication.

Scale indicators10 records

Recent moves6 records

Expansion highlights6 records

Emerging players

• LillyDirect: Eli Lilly's manufacturer-direct online platform is a peer in the manufacturer-direct-to-patient channel. TrumpRx redirects patients to LillyDirect for Zepbound and other Lilly medications, making them channel partners on TrumpRx while competing for the same cash-pay patient.
• Honeybee Health: Honeybee Health is an online pharmacy offering transparent pricing on generic medications direct-to-consumer, comparable in model to Cost Plus Drugs and an emerging peer in the cash-pay online pharmacy segment that TrumpRx increasingly aggregates.

Direct peers

• GoodRx: GoodRx is the closest direct peer, operating a consumer-facing prescription drug discount and price comparison platform with a pharmacy network discount card model. GoodRx is also TrumpRx's core technology integration partner, powering its discounted cash pricing engine.
• SingleCare: SingleCare is a direct competitor offering a prescription drug discount card and price comparison platform with similar mechanics to TrumpRx, including pharmacy network acceptance and cash-pay discount coupons for the uninsured market.
• Amazon Pharmacy: Amazon Pharmacy is a direct peer in online prescription drug delivery and pricing. It is integrated with TrumpRx as a home delivery pharmacy option for generic medications, offering 1-4 day delivery with Prime membership.
• RxSaver: RxSaver (owned by RetailMeNot) is a direct competitor offering prescription drug discount coupons and price comparison, with similar mechanics to GoodRx and a pharmacy network acceptance model comparable to TrumpRx's CVS integration.
• Cost Plus Drug Company: Mark Cuban's Cost Plus Drug Company is a direct peer offering transparent cost-plus-markup prescription drugs direct-to-consumer. It supplies 559 drugs on the TrumpRx platform and is positioned as a key generic distribution and mail-order partner.

Broad incumbents

• Express Scripts: Express Scripts is one of the largest U.S. PBMs and a broad incumbent in prescription drug benefit management. TrumpRx is positioned explicitly as a PBM-bypass channel, making Express Scripts a structural competitor to the TrumpRx model.
• CVS Health: CVS Health operates the largest U.S. retail pharmacy chain plus the Caremark PBM. While 9,000 CVS pharmacies accept TrumpRx discount cards, CVS is also a structural competitor via Caremark's formulary/PBM business that TrumpRx explicitly bypasses.
• Optum Rx: Optum Rx is the largest U.S. PBM and a broad incumbent in pharmacy benefit management. Like Express Scripts, it represents the type of intermediary TrumpRx is positioned against and competes with for cash-pay drug distribution economics.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about TrumpRx